Get App
PRE-MARKET REPORT
The domestic equity market indices, Sensex and Nifty 50, are expected to open lower on Thursday amid mixed cues from global markets and fears of a full-fledged war between Iran and Israel.
Gift Nifty was trading around the 25,725 level, a discount of nearly 250 points from the Nifty futures’ previous close, indicating a gap-down start for the Indian stock market indices.
US stock market ended with modest gains on Wednesday led by gains in technology shares, but investors remain cautious amid Middle East tensions and more US labor data due this week.
The Dow Jones Industrial Average gained 39.55 points, or 0.09%, to 42,196.52, while the S&P 500 rose 0.79 points, or 0.01%, to 5,709.54. The Nasdaq Composite ended 14.76 points, or 0.08%, higher at 17,925.12.
Asian markets traded higher on Thursday following overnight gains on Wall Street. Japan’s Nikkei 225 rose 2.57%, while the Topix added 2%. Hong Kong’s Hang Seng index futures indicated a slightly lower opening. Markets in China and South Korea are shut for the holidays.
STOCKS TODAY
Mankind Pharma: The company has received regulatory approvals, including approval from the Competition Commission of India, for acquiring Bharat Serums and Vaccines. In July 2024, the Share Purchase Agreement was executed between the company, Bharat Serums and Vaccines, the sellers (Ansamira and Miransa—affiliates of funds managed by Advent International), and certain minority shareholders (Bhaskar Iyer and Abhijit Mukherjee) for the acquisition of a 100% stake in Bharat Serums and Vaccines.
Zydus Lifesciences: The pharmaceutical company has received tentative approval from the USFDA to manufacture Enzalutamide tablets in 40 mg and 80 mg strengths. Enzalutamide is used for treating castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
Ashoka Buildcon: The infrastructure company has received a letter of award for a project worth Rs 474.10 crore from MMRDA, involving the design and construction of an elevated road from Kalyan Murbad Road to Badlapur Road to Pune Link. Additionally, it has bagged two more letters of award for contracts worth Rs 1,264 crore, which include the design and construction of a creek bridge from Kolshet to Kalher, and another from Gaimukh to Payegaon.
Eicher Motors: Royal Enfield sales increased by 11% year-on-year to 86,978 units, exceeding analysts’ estimates, compared to 78,580 units sold in September last year. Exports in September jumped by 77% to 7,652 units, compared to 4,319 units in the same month the previous year.
Hero MotoCorp: The two-wheeler major has announced sales of 6.37 lakh units in September 2024, beating analysts’ estimates and growing by 18.7% over the 5.36 lakh units sold in the same month last year. Domestic sales increased by 18.6% year-on-year to 6.16 lakh units, and exports grew by 21.7% to 20,344 units during the month.
Maruti Suzuki India: The country’s largest carmaker recorded total sales of 1.84 lakh units in September 2024, marking a 1.9% increase from the 1.81 lakh units sold in the same month last year. Total domestic sales fell by 1.15% to 1.57 lakh units, as domestic passenger vehicle sales dropped by 3.9% to 1.45 lakh units. However, total exports jumped by 23.2% to 27,728 units compared to September 2023.